Modulation of Elk-dependent-transcription by gene33

Journal of Cellular Biochemistry

Volumn 94, Issue 6, 2005, Pages 1190-1198

  Keeton, Adam B ^a   Messina, Joseph L ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

c Jun; Elk; ERK; Gene33; JNK; Transcription

Indexed keywords

CYTOPLASM PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITOPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; POLYCLONAL ANTIBODY; PROTEIN 14 3 3; PROTEIN CDC42; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE; GENE 33; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CELL LINE; HUMANS; LUCIFERASES; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 26444455690     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20370     Document Type: Article

References (33)

1. Anastasi S, Florentino L, Fiorini M, Fraioli R, Sala G, Castellani L, Alema S, Alimandi M, Segatto O. 2003. Feedback inhibition by RALT controls signal output by the ErbB network. Oncogene 22:4221-4234.
2. Brasier AR, Tate JE, Habener JF. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116-1122.
3. Cohen GB, Ren R, Baltimore D. 1995. Modular binding domains in signal transduction proteins. Cell 80:237-248.
4. Dhillon AS, Meikle S, Yazici Z, Eulitz M, Kolch W. 2002. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J 21:64-71.
5. Florentino L, Pertica C, Fiorini M, Talora C, Crescenzi M, Castellani L, Alema S, Benedetti P, Segatto O. 2000. Inhibition of ErbB-2 mitogenic and transforming activity by RALT (Gene33), a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol 20:7735-7750.
6. Fiorini M, Ballaro C, Sala G, Falcone G, Alema S, Segatto O. 2002. Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control. Oncogene 21:6530-6539.
7. Haber BA, Mohn KL, Diamond RH, Taub R. 1993. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 91:1319-1326.
8. Hackel PO, Gishizky M, Ullrich A. 2001. Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biol Chem 382:1649-1662.
9. Ji S, Guan R, Frank SJ, Messina JL. 1999. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem 274:13434-13442.
10. Keeton AB, Amsler MO, Venable DY, Messina JL. 2002. Insulin signal transduction pathways and insulin-induced gene expression. J Biol Chem 277:48565-48573.
11. Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, Messina JL. 2003. Insulin-regulated expression of Egr-1 and Krox20: Dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology 144:5402-5410.
12. Keeton AB, Xu J, Franklin JL, Messina JL. 2004. Regulation of Gene33 expression by insulin requires MEK-ERK activation. Biochim Biophys Acta 1679:248-255.
13. Kent TA, Messina JL, Weinstock RS, Stein JP. 1994. Synergistic induction of gene 33 expression by retinoic acid and insulin. Endocrinology 134:2237-2244.
14. Lee KL, Isham KR, Stringfellow L, Rothrock R, Kenney FT. 1985. Molecular cloning of cDNAs cognate to genes sensitive to hormonal control in rat liver. J Biol Chem 260:16433-16438.
15. Li X, Lee JW, Graves LM, Earp HS. 1998. Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17:2574-2583.
16. Lin A, Minden A, Martinetto H, Claret F-X, Lange-Carter C, Mercurio F, Johnson GL, Karin M. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268:286-290.
17. Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, Bonventre JV, Kyriakis JM. 2000. Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress. J Biol Chem 275:17838-17847.
18. Manser E, Chong C, Zhao ZS, Leung T, Michael G, Hall C, Lim L. 1995. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J Biol Chem 270:25070-25078.
19. Marais R, Wynne J, Treisman R. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
20. Messina JL. 1989. Insulin and dexamethasone regulation of a rat hepatoma messenger ribonucleic acid: Insulin has a transcriptional and a posttranscriptional effect. Endocrinology 124:754-761.
21. Messina JL. 1994. Regulation of gene 33 expression by insulin. In: Draznin B, Leroith D, editors. Molecular biology of diabetes. Part II. Insulin actions, effects on gene expression and regulation and glucose transport. Totowa, NJ: The Humana Press Inc. pp 263-281.
22. Messina JL, Hamlin J, Larner J. 1987. Positive interaction between insulin and phorbol esters on the regulation of a specific messenger ribonucleic acid in rat hepatoma cells. Endocrinology 121:1227-1232.
23. Mohn KL, Laz TM, Melby AE, Taub R. 1990. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the Jun, Fos, and Egr families. J Biol Chem 265:21914-21921.
24. Reks SE, Smith PH, Messina JL, Weinstock RS. 1998. Activation of PKC delta by insulin in a rat hepatoma cell line. Endocrine 8:161-167.
25. Robinson MJ, Cobb MH. 1997. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186.
26. Saarikoski ST, Rivera SP, Hankinson O. 2002. Mitogen-inducible gene 6 (MIG-6), adipophilin and tuftelin are inducible by hypoxia. FEBS Lett 530:186-190.
27. Sadowski I, Ptashne M. 1989. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res 17:7539.
28. Shi ZQ, Lu W, Feng GS. 1998. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J Biol Chem 273:4904-4908.
29. Tsunoda T, Inokuchi J, Baba I, Okumura K, Naito S, Sasazuki T, Shirasawa S. 2002. A novel mechanism of nuclear factor kappaB activation through the binding between inhibitor of nuclear factor-kappaBalpha and the processed NH(2)-terminal region of Mig-6. Cancer Res 62:5668-5671.
30. Varley CL, Armitage S, Dickson AJ. 1999. Activation of stress-activated protein kinases by hepatocyte isolation induces gene 33 expression. Biochem Biophys Res Comm 254:728-733.
31. Weinstock RS, Manning CA, Messina JL. 1992. The regulation of p33 gene expression by insulin and calcium ionophores. Endocrinology 130:616-624.
32. Wick M, Burger C, Funk M, Muller R. 1995. Identification of a novel mitogen-inducible gene (mig-6): Regulation during G1 progression and differentiation. Exp Cell Res 219:527-535.
33. Xia ZG, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.